REFERENCES
- Frank A, Deng S, Huang X, . Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg. 2004;240:631–640.
- Hering BJ, Kandaswamy R, Ansite JD, . Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA. 2005;293:830–835.
- Shapiro AM, Ricordi C, Hering BJ, . International trial of the Edmonton protocol for islet transplantation. New Engl J Med. 2006;355:1318–1330.
- Hering BJ. Achieving and maintaining insulin independence in human islet transplant recipients. Transplantation. 2005;79:1296–1297.
- Rickels MR, Schutta MH, Markmann JF, . beta-Cell function following human islet transplantation for type 1 diabetes. Diabetes. 2005;54:100–106.
- Korsgren O, Nilsson B, Berne C, . Current status of clinical islet transplantation. Transplantation. 2005;79:1289–1293.
- Weber DJ, McFarland RD, Irony I. Selected Food and Drug Administration review issues for regulation of allogeneic islets of Langerhans as somatic cell therapy. Transplantation. 2002;74:1816–1820.
- Knazek RA. The human pancreatic islet cell resource consortium. Diabetes Technol Ther. 2002;4:551–552.
- Eckhoff DE, Eckstein C, Smyth CA, . Enhanced isolated pancreatic islet recovery and functionality in rats by 17 beta-estradiol treatment of brain death donors. Surgery. 2004;136:336–345.
- Contreras JL, Eckstein C, Smyth CA, . Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes. 2003;52:2935–2942.
- Bretzel RG, Alejandro R, Hering BJ, . Clinical islet transplantation: guidelines for islet quality control. Transplant Proc. 1994;26:388–392.
- Paraskevas S, Aikin R, Maysinger D, . Activation and expression of ERK, JNK, and p38 MAP-kinases in isolated islets of Langerhans: implications for cultured islet survival. FEBS Lett. 1999;455:203–208.
- Paraskevas S, Maysinger D, Wang R, . Cell loss in isolated human islets occurs by apoptosis. Pancreas. 2000;20:270–276.
- Papas KK, Hering BJ, Guenther L, . Pancreas oxygenation is limited during preservation with the two-layer method. Transplant Proc. 2005;37:3501–3504.
- Papas KK, Colton CK, Qipo A, . Islet quality assay based on oxygen consumption rate and DNA measurements predicts graft function in mice. Cell Transplant. 2003;12:176.
- Goto M, Holgersson J, Kumagai-Braesch M, . The ADP/ATP ratio: a novel predictive assay for quality assessment of isolated pancreatic islets. Am J Transplant. 2006;6:2483–2487.
- Fraker C, Timmins MR, Guarino RD, . The use of the BD oxygen biosensor system to assess isolated human islets of Langerhans: oxygen consumption as a potential measure of islet potency. Cell Transplant. 2006;15:745–758.
- Ichii H, Inverardi L, Pileggi A, . A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant. 2005;5:1635–1645.
- Armann B, Hanson MS, Hatch E, . Quantification of basal and stimulated ROS levels as predictors of islet potency and function. Am J Transplant. 2007;7:38–47.
- Papas KK, Colton CK, Nelson RA, . Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant. 2007;7:707–713.
- Sweet IR, Gilbert M, Jensen R, . Glucose stimulation of cytochrome C reduction and oxygen consumption as assessment of human islet quality. Transplantation. 2005;80:1003–1011.
- Fernandez LA, Hatch EW, Armann B, . Validation of large particle flow cytometry for the analysis and sorting of intact pancreatic islets. Transplantation. 2005;80:729–737.
- Pisania A. Development of quantitative methods for quality assessment of islets of Langerhans. Ph.D. thesis, 2007, Massachusetts Institute of Technology, Cambridge, MA.
- Emamaullee JA, Stanton L, Schur C, . Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes. 2007;56:1289–1298.
- Berman DM, Cabrera O, Kenyon NM, . Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation. 2007;84:308–315.
- Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 1967;16:35–39.
- Papas KK, Pisania A, Wu H, . A stirred microchamber for oxygen consumption rate measurements with pancreatic islets. Biotechnol Bioeng. 2007;98:1071–1082.
- Ghobrial RR, Boublik M, Winn HJ, . In vivo use of monoclonal antibodies against murine T cell antigens. Clin Immunol Immunopathol. 1989;52:486–506.
- Dialynas DP, Quan ZS, Wall KA, . Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol. 1983;131:2445–2451.
- Colton CK, Papas KK, Pisania, A, Rappel MJ, Powers DE, O'Neil JJ, Omer A, Weir G, and Bonner-Weir S. Characterization of Islet Preparations, In “Cell Transplantation from Laboratory to Clinic” Craig Halberstadt and Dwaine F. Emerich, editors, Elsevier, Inc., New York, 2006, Chapter 6, pages 85–133.
- Suzuki K, Bonner-Weir S, Trivedi N, . Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice. Transplantation. 1998;66: 21–28.
- Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes. 2004;53:S16–S21.